Minimizing Glucose Excursions (GEM) With Continuous Glucose Monitoring in Type 2 Diabetes: A Randomized Clinical Trial
Open accessThe DOI matches its Crossref record; 15 of the 15 references it cites were found in a registry or an index.
Abstract
This study aimed to compare conventional medication management of type 2 diabetes (T2D) to medication management in conjunction with a lifestyle intervention using continuous glucose monitoring to minimize glucose excursions. Thirty adults (63% female; mean age, 53.3 years) who were diagnosed with T2D for less than 11 years (mean, 5.6 years), had glycated A1c (HbA1c) ≥ 7.0% (51 mmol/mol) (mean 8.8%, [73 mmol/mol]), and were not using insulin, were randomly assigned in a 1:2 ratio to routine care (RC) or 4 group sessions of glycemic excursion minimization plus real-time CGM (GEMCGM). Assessments at baseline and 5 months included a physical exam, metabolic and lipid panels, a review of diabetes medications, and psychological questionnaires. For the week following assessments, participants wore a blinded activity monitor and completed 3 days of 24-hour dietary recall. A subgroup also wore a blinded CGM. GEMCGM participants significantly improved HbA1c (from 8.9% to 7.6% [74-60 mmol/mol] compared with 8.8% to 8.7% [73-72 mmol/mol] for RC (P = .03). Additionally, GEMCGM reduced the need for diabetes medication (P = .01), reduced carbohydrate consumption (P = .009), and improved diabetes knowledge (P = .001), quality of life (P = .01) and diabetes distress (P = .02), and trended to more empowerment (P = .05) without increasing dietary fat, lipids, or hypoglycemia. Confirming our prior research, GEMCGM appears to be a safe, effective lifestyle intervention option for adults with suboptimally controlled T2D who do not take insulin.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Figures


Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
The cited source says what the claim attributes to it.
In the citing paper
“Cox and colleagues reported lower carbohydrate consumption and higher empowerment and knowledge scores with lower diabetes distress in noninsulin users who had received the CGM plus education intervention. 50”
The cited source says what the claim attributes to it.
In the citing paper
“Furthermore, rtCGM has been associated with improvements in the medication effect score (MES) and the Diabetes Distress Scale (DDS) 50 while isCGM has been positively linked with the Summary of Diabetes Self‐Care Activities Questionnaire (SDSCA‐K). 28 , 30”
The cited source says what the claim attributes to it.
In the citing paper
“Imputing the maximum SD in place of the mean SD in the trial by Cox and colleagues 50 did not affect the significance of the results for TIR, TBR, and TAR outcomes.”
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
The PHQ-9: Validity of a brief depression severity measure
Kroenke, K., Spitzer, R. L., & Williams, J. B. W. (2001) · Journal of General Internal Medicine · doi:10.1046/j.1525-1497.2001.016009606.x · Cited by 44,910
Standards of Medical Care in Diabetes
Power, D. (2006) · Diabetes Care · doi:10.2337/diacare.29.02.06.dc05-1593 · Cited by 8,673
Davies, M. J., D’Alessio, D. A., Fradkin, J., Kernan, W. N., Mathieu, C., Mingrone, G., Rossing, P., Tsapas, A., Wexler, D. J., & Buse, J. B. (2018) · Diabetes Care · doi:10.2337/dci18-0033 · Cited by 3,518 · cited 1×
“The American Diabetes Association recommends 150 minutes per week of moderate physical activity plus 7% weight loss through caloric restriction [1].”
BackgroundAssessing Psychosocial Distress in Diabetes
Polonsky, W. H., Fisher, L., Earles, J., Dudl, R. J., Lees, J., Mullan, J., & Jackson, R. A. (2005) · Diabetes Care · doi:10.2337/diacare.28.3.626 · Cited by 1,575
Subar, A. F., Kirkpatrick, S. I., Mittl, B., Zimmerman, T. P., Thompson, F. E., Bingley, C., Willis, G., Islam, N. G., Baranowski, T., McNutt, S., et al. (2012) · Journal of the Academy of Nutrition and Dietetics · doi:10.1016/j.jand.2012.04.016 · Cited by 934
International Hypoglycaemia Study Group (2017) · Diabetes Care · doi:10.2337/dc16-2215 · Cited by 608
The Diabetes Empowerment Scale: a measure of psychosocial self-efficacy.
Anderson, R. M., Funnell, M. M., Fitzgerald, J. T., & Marrero, D. G. (2000) · Diabetes Care · doi:10.2337/diacare.23.6.739 · Cited by 568
The International Hypoglycaemia Study Group (2017) · Diabetologia · doi:10.1007/s00125-016-4146-6 · Cited by 360
Introduction: Standards of Medical Care in Diabetes—2020
(2020) · Diabetes Care · doi:10.2337/dc20-sint · Cited by 331
Postprandial hyperglycaemia and cardiovascular complications of diabetes: An update
Ceriello, A., Davidson, J., Hanefeld, M., Leiter, L. A., Monnier, L., Owens, D. R., Tajima, N., & Tuomilehto, J. O. (2006) · Nutrition Metabolism and Cardiovascular Diseases · doi:10.1016/j.numecd.2006.05.006 · Cited by 166
Research works printed but not linked: 2
- Cox DJ, Basu R, McCall A. Continuous glucose monitoring functions as a negative feedback loop for individuals with type 2 diabetes. Ann Diabetes Metab Disorders Control. 2018; 1(3): 121.
- World Health Organization. The world health organization quality of life (WHOQOL)-BREF. No. WHO/HIS/HSI Rev. 2012.02. World Health Organization, 2004.
Cited by
Seidu, S., Kunutsor, S. K., Ajjan, R. A., & Choudhary, P. (2024) · Diabetes Care · doi:10.2337/dc23-1520 · Cited by 124
Aronson, R., Brown, R. E., Chu, L., Bajaj, H. S., Khandwala, H., Abitbol, A., Malakieh, N., & Goldenberg, R. (2023) · Diabetes, Obesity and Metabolism · doi:10.1111/dom.14949 · Cited by 118
Continuous glucose monitoring for the routine care of type 2 diabetes mellitus
Ajjan, R. A., Battelino, T., Cos, X., Del Prato, S., Philips, J.-C., Meyer, L., Seufert, J., & Seidu, S. (2024) · Nature Reviews Endocrinology · doi:10.1038/s41574-024-00973-1 · Cited by 117
“…in people with T2DM not on insulin therapy, include: increased hypo-glycaemic confidence, reduced diabetes mellitus distress and better overall wellbeing 79,80 , as well as improved psychological function, diabetes mellitus empowerment and greater diabetes mellitus treatment satisfaction 62,63 .”
Type 2 Diabetes and the Use of Real-Time Continuous Glucose Monitoring
Jackson, M. A., Ahmann, A., & Shah, V. N. (2021) · Diabetes Technology & Therapeutics · doi:10.1089/dia.2021.0007 · Cited by 106
“created a model using education and lifestyle interventions to minimize glucose excursions and employed rtCGM (Dexcom Platinum G4) to educate patients on the effects of eating and activity choices previously demonstrated to reduce glycemic variability.(22) They found not only an improvement in HbA1c but also a remarka…”
MethodFerreira, R. O. M., Trevisan, T., Pasqualotto, E., Chavez, M. P., Marques, B. F., Lamounier, R. N., & van de Sande-Lee, S. (2024) · Diabetes Technology & Therapeutics · doi:10.1089/dia.2023.0390 · Cited by 92
Oser, T. K., Hall, T. L., Dickinson, L. M., Callen, E., Carroll, J. K., Nease, D. E., Michaels, L., & Oser, S. M. (2022) · The Annals of Family Medicine · doi:10.1370/afm.2876 · Cited by 72
Mayberry, L. S., Guy, C., Hendrickson, C. D., McCoy, A. B., & Elasy, T. (2023) · Journal of General Internal Medicine · doi:10.1007/s11606-023-08222-3 · Cited by 77
Price, D. A., Deng, Q., Kipnes, M., & Beck, S. E. (2021) · Diabetes Therapy · doi:10.1007/s13300-021-01086-y · Cited by 77
“[29] looked at the benefit of a formal, group-oriented, structured education program in conjunction with rtCGM (worn for five sessions) in 30 subjects with early T2D and found that participants using rtCGM successfully modified their diets and lowered their HbA1c on the basis of their CGM data and the structured educa…”
MethodMoon, S. J., Kim, K., Lee, W. J., Lee, M. Y., Vigersky, R., & Park, C. (2023) · Diabetes, Obesity and Metabolism · doi:10.1111/dom.14852 · Cited by 69
“Those studies included subjects who used a small number of or no OADs.(16,28) Also, they did not assess SMBG use in the CGM group.”
BackgroundMethodInfluentialOser, T. K., Litchman, M. L., Allen, N. A., Kwan, B. M., Fisher, L., Jortberg, B. T., Polonsky, W. H., & Oser, S. M. (2021) · Current Diabetes Reports · doi:10.1007/s11892-021-01408-1 · Cited by 43
Nathanson, D., Eeg‐Olofsson, K., Spelman, T. D., Bülow, E., Kyhlstedt, M., Levrat‐Guillen, F., & Bolinder, J. (2024) · Diabetologia · doi:10.1007/s00125-024-06289-z · Cited by 40
Tan, Y. Y., Suan, E., Koh, G. C. H., Suhairi, S. B., & Tyagi, S. (2024) · Archives of Public Health · doi:10.1186/s13690-024-01459-2 · Cited by 35
Layne, J. E., Jepson, L. H., Carite, A. M., Parkin, C. G., & Bergenstal, R. M. (2024) · Diabetes Technology & Therapeutics · doi:10.1089/dia.2024.0197 · Cited by 37
Battelino, T., Lalic, N. M., Hussain, S., Ceriello, A., Majanović, S. K., Davies, S., Topsever, P., Heverly, J., Ulivi, F., Brady, K., et al. (2025) · Diabetes Research and Clinical Practice · doi:10.1016/j.diabres.2025.112111 · Cited by 36
Aleppo, G., Hirsch, I. B., Parkin, C. G., McGill, J., Galindo, R., Kruger, D. F., Levy, C. J., Forlenza, G. P., Umpierrez, G. E., Grunberger, G., et al. (2023) · Diabetes Technology & Therapeutics · doi:10.1089/dia.2023.0268 · Cited by 34
“HbA1c was significantly decreased from baseline in the isCGM group at 24 weeks ( - 0.46%, P < 0.001), but not the BGM group ( - 0.17%, P = 0.124); a significant between-group difference was also observed ( - 0.29%, P = 0.022).”
InfluentialAronson, R., Abitbol, A., Bajaj, H. S., Cheng, A. Y. Y., Christopoulos, S., Harris, S. B., Jain, A. B., & Goldenberg, R. M. (2025) · Diabetes, Obesity and Metabolism · doi:10.1111/dom.70008 · Cited by 33
“Furthermore, rtCGM has been associated with improvements in the medication effect score (MES) and the Diabetes Distress Scale (DDS) 50 while isCGM has been positively linked with the Summary of Diabetes Self-Care Activities Questionnaire (SDSCA-K).”
InfluentialContinuous glucose monitoring in persons with type 2 diabetes not using insulin
Cowart, K., Updike, W. H., & Franks, R. (2021) · Expert Review of Medical Devices · doi:10.1080/17434440.2021.1992274 · Cited by 27
Shields, S., Thomas, R., Durham, J., Moran, J., Clary, J., & Ciemins, E. L. (2024) · Scientific Reports · doi:10.1038/s41598-024-83548-4 · Cited by 28
Oser, T. K., Cucuzzella, M. T., Stasinopoulos, M., MONCRIEF, M. A., McCall, A. L., & Cox, D. J. (2022) · JMIR Diabetes · doi:10.2196/34465 · Cited by 27
Self-citationvan den Burg, E. L., Schoonakker, M. P., van Peet, P. G., van den Akker-van Marle, E. M., Lamb, H. J., Longo, V. D., Numans, M. E., & Pijl, H. (2024) · Diabetologia · doi:10.1007/s00125-024-06137-0 · Cited by 25
Martens, T. W., Willis, H. J., Bergenstal, R. M., Kruger, D. F., French, E. K., & Steenkamp, D. (2025) · Diabetes Technology & Therapeutics · doi:10.1089/dia.2024.0579 · Cited by 25
The use of technology in type 2 diabetes and prediabetes: a narrative review
Liarakos, A. L., Lim, J. Z. M., Leelarathna, L., & Wilmot, E. G. (2024) · Diabetologia · doi:10.1007/s00125-024-06203-7 · Cited by 27
Wright, E. E., Roberts, G. J., Chuang, J. S., Nabutovsky, Y., Virdi, N., & Miller, E. (2024) · Diabetes Technology & Therapeutics · doi:10.1089/dia.2024.0015 · Cited by 22
Cox, D. J., Banton, T., Moncrief, M., Conaway, M., Diamond, A., Holmes, V., Green Pastors, J., Wolf, A., Fang, K., & McCall, A. (2020) · BMJ Open Diabetes Research & Care · doi:10.1136/bmjdrc-2020-001795 · Cited by 20
Self-citationEvolving Use of Continuous Glucose Monitoring Beyond Intensive Insulin Treatment
Wright, E. E., & Subramanian, S. (2021) · Diabetes Technology & Therapeutics · doi:10.1089/dia.2021.0191 · Cited by 20
Bannuru, R. R., Bellini, N. J., Bergenstal, R. M., Beverly, E. A., Christofides, E. A., Cox, D. J., Ehrhardt, N. M., Fazioli, K., Fischl, A. H., Kerr, D. E., et al. (2025) · Journal of Diabetes Science and Technology · doi:10.1177/19322968251384318 · Cited by 20
Self-citationUngersboeck, M., Tang, X., Neeff, V., Steele, D., Grimm, P., & Fenech, M. E. (2022) · Nutrients · doi:10.3390/nu14102123 · Cited by 20
Zheng, Y., Campbell Rice, B., Melkus, G. D., Sun, M., Zweig, S., Jia, W., Parekh, N., He, H., Zhang, Y., & Wylie-Rosett, J. (2023) · Journal of Diabetes Science and Technology · doi:10.1177/19322968231174038 · Cited by 17
Zhang, D., Huang, J., Zhang, Y. H., Wei, Z., Long, T., Guo, X., & Li, M. (2025) · Diabetes Research and Clinical Practice · doi:10.1016/j.diabres.2025.112907 · Cited by 17
Patient‐reported outcomes in studies of diabetes technology: What matters
Liarakos, A. L., Crabtree, T. S. J., & Wilmot, E. G. (2024) · Diabetes Obesity and Metabolism · doi:10.1111/dom.15858 · Cited by 19
Advances in diabetes technology within the digital diabetes ecosystem
Aktürk, H. K., & Bindal, A. (2024) · Journal of Managed Care & Specialty Pharmacy · doi:10.18553/jmcp.2024.30.10-b.s7 · Cited by 22
Peng, M., Shen, P., & Kim, K. J. (2026) · International Journal of Behavioral Nutrition and Physical Activity · doi:10.1186/s12966-025-01870-0 · Cited by 12
Cox, D. J., Oser, T., Moncrief, M., Conaway, M., & McCall, A. (2021) · BMJ Open Diabetes Research & Care · doi:10.1136/bmjdrc-2021-002403 · Cited by 11
Self-citationThe Role of Advanced Technologies in Improving Diabetes Outcomes
Marrero, D. G., Parkin, C. G., Aleppo, G., Hirsch, I. B., McGill, J. B., Galindo, R. J., Kruger, D. F., Levy, C. J., Carlson, A. L., & Umpierrez, G. E. (2025) · The American Journal of Managed Care · doi:10.37765/ajmc.2025.89725 · Cited by 13
Ehrhardt, N. M., Montour, L., Berberian, P., Vasconcelos, A. G., Comstock, B. A., & Wright, L. A.-C. (2025) · Journal of Diabetes Science and Technology · doi:10.1177/19322968251331526 · Cited by 9
Hall, T. L., Dickinson, L. M., Warman, M. K., Oser, T. K., & Oser, S. M. (2024) · Journal of the American Association of Nurse Practitioners · doi:10.1097/jxx.0000000000001060 · Cited by 8
Hirsch, I. B., Parkin, C. G., Cavaiola, T. S., & Bergenstal, R. M. (2024) · Diabetes Obesity and Metabolism · doi:10.1111/dom.15883 · Cited by 8
Morris-Murray, M., & Frazzitta, M. A. (2024) · Journal of Managed Care & Specialty Pharmacy · doi:10.18553/jmcp.2024.30.10-b.s30 · Cited by 11
Enhancing Type 2 Diabetes Care With CGM Integration: Insights From an Italian Expert Group
Irace, C., Avogaro, A., Bertuzzi, F., Buzzetti, R., Candido, R., Prato, S. D., Bartolo, P. D., Fiorina, P., Giorda, C. B., & Giorgino, F. (2025) · Diabetes/Metabolism Research and Reviews · doi:10.1002/dmrr.70059 · Cited by 7
Clinical Impact of Continuous Glucose Monitoring in Noninsulin Treated Type 2 Diabetes: A Review
Aleppo, G., Carlson, A. L., McGill, J. B., Alshannaq, H. A., Galindo, R. J., Kruger, D. F., Levy, C. J., Matuoka, J. Y., Ilham, S., Umpierrez, G. E., et al. (2026) · Diabetes Technology & Therapeutics · doi:10.1177/15209156251414980 · Cited by 6
Continuous Glucose Monitoring in Individuals With Type 2 Diabetes: A Quality Improvement Program
Kinson, L., & Inman, K. (2024) · Clinical Diabetes · doi:10.2337/cd24-0006 · Cited by 5
Wiggins, K. T., Hall, T. L., Jortberg, B. T., Dickinson, W. P., Dickinson, L. M., Parascando, J. A., Fernald, D. H., Sobczak, C., Oser, S. M., & Oser, T. K. (2025) · BMC Family Practice · doi:10.1186/s12875-025-02903-0 · Cited by 7
Parsiani, R., Grace, T., Green, C. R., Castle, J. R., & Wilson, L. M. (2025) · Journal of Family Medicine and Primary Care · doi:10.4103/jfmpc.jfmpc_773_24 · Cited by 5
Ettestad, T. M., Willis, H. J., Johnson, E. M., Green, C. R., & Bergenstal, R. M. (2025) · Clinical Diabetes · doi:10.2337/cd24-0106 · Cited by 4
Willis, H. J., Gustafson, S. K., Johnson, E. M., JaKa, M. M., & Bergenstal, R. M. (2025) · Diabetes Technology & Therapeutics · doi:10.1177/15209156251377799 · Cited by 4
Continuous Glucose Monitoring: An Opportunity for Population-Based Diabetes Management
Skoufalos, A., Thomas, R., Patel, R. R., Mei, C., & Clarke, J. L. (2022) · Population Health Management · doi:10.1089/pop.2022.0196 · Cited by 5
Courtney, A., Smith, D., & Forde, H. E. (2023) · Irish Journal of Medical Science (1971 -) · doi:10.1007/s11845-023-03322-9 · Cited by 4
Cowart, K., & Carris, N. W. (2021) · JAMA · doi:10.1001/jama.2021.13472 · Cited by 4
Oriot, P., Bui, L., kurz, N. K. D., Gavriliu, M. M., Negrea, M.-C., & Hermans, M. P. (2025) · Acta Clinica Belgica · doi:10.1080/17843286.2025.2528030 · Cited by 3
Olu-Jordan, I., Singh, P. K., Zheng, J. R., Yeung, R. O., Manca, D. P., Perry, T., Rahim, G., Hagen, E., & Lau, D. (2025) · Canadian Journal of Diabetes · doi:10.1016/j.jcjd.2025.10.174 · Cited by 3
Dennis, C., Allaire, J. C., Bouhairie, V. E., & Hirsch, I. B. (2025) · Diabetes Technology & Therapeutics · doi:10.1177/15209156251403569 · Cited by 3
Morrow, E. L., Spieker, A. J., Greevy, R. A., Roddy, M. K., & Mayberry, L. S. (2024) · Journal of General Internal Medicine · doi:10.1007/s11606-024-09101-1 · Cited by 2
Case Studies From India: Management of Diabetes Using Continuous Glucose Monitoring
Gupta, A. K., Krishnan, A. S., Kataria, M., & Jain, N. (2025) · Cureus · doi:10.7759/cureus.93177 · Cited by 2
Sebastian, S. A., Padda, I., Bimal, T., Varma, S., Collins, J. S. P., Ahmad, Z., & Safarova, M. S. (2025) · Disease-a-Month · doi:10.1016/j.disamonth.2025.102043 · Cited by 3
Streetman, A. E., Walden, R. L., Orr, C. J., & Heerman, W. J. (2025) · International Journal of Behavioral Nutrition and Physical Activity · doi:10.1186/s12966-025-01859-9 · Cited by 2
Dwiastuti, A., Latarissa, I. R., Hidayat, A., Halimah, E., & Lestari, K. (2026) · Diabetes Metabolic Syndrome and Obesity · doi:10.2147/dmso.s561759 · Cited by 2
Hayek, A. A., Klonoff, D. C., Zahrani, W. M. A., Indarkiri, N. Y., & Dawish, M. A. A. (2026) · Advances in Therapy · doi:10.1007/s12325-026-03495-6 · Cited by 2
Giaccari, A., Gliozzo, G., Ciccarelli, G., Giuseppe, G. D., Castellano, C., Cum, S., Monache, L. D., Gallo, M., Lastretti, M., Medea, G., et al. (2026) · Acta Diabetologica · doi:10.1007/s00592-026-02693-6 · Cited by 2
Nasser, S. A., Lovre, D., Tajrishi, F. Z., & Ferdinand, K. C. (2025) · Endocrine Research · doi:10.1080/07435800.2025.2577643 · Cited by 2
Lazar, D., Tao, M., Matievich, W., Kastanos, K., & Dunn, T. C. (2024) · Journal of Diabetes Science and Technology · doi:10.1177/19322968241260038 · Cited by 2
Lian, X., Cheng, L. J., Teo, C. J. Y., Tan, J., Lim, H., Shen, L., Chew, H. S. J., Wang, W., & Dalan, R. (2026) · Frontiers in Endocrinology · doi:10.3389/fendo.2025.1761579 · Cited by 1
Hayek, A. A., Zahrani, W. M. A., Alotaibi, H. F., Saleh, J. Y., & Dawish, M. A. A. (2026) · Primary care diabetes · doi:10.1016/j.pcd.2026.04.002 · Cited by 1
Hayek, A. A., Zahrani, W. M. A., Alotaibi, H. F., & Dawish, M. A. A. (2026) · Journal of Diabetes Science and Technology · doi:10.1177/19322968261447256 · Cited by 1
Fernández-Rubio, E., Blanco, J. A., Casanova, L. G., Martínez, I. M. P., Pérez, M. G., Torralba, M. E. S., Ruano, M. A. R., González, C., & Ampudia‐Blasco, F. J. (2026) · Endocrinología Diabetes y Nutrición · doi:10.1016/j.endinu.2026.501829 · Cited by 1
Nontraditional Uses of Continuous Glucose Monitoring
Kapsar, P., Chao, C., & Walker, T. C. (2022) · The Journal for Nurse Practitioners · doi:10.1016/j.nurpra.2022.06.013 · Cited by 1
Seufert, J., Dänschel, I., Gölz, S., Haller, N., Kulzer, B., Tan, S., Schnell, O., Wiesner, T., & Kroeger, J. (2024) · Diabetologie und Stoffwechsel · doi:10.1055/a-2305-9093 · Cited by 1
DePietro, R., & Cronk, N. J. (2023) · Evidence-Based Practice · doi:10.1097/ebp.0000000000001860
What Do You Need to Know About Continuous Glucose Monitoring?
Cedeno, A., & Carmichael, K. A. (2021) · Consultant · doi:10.25270/con.2021.01.00006
Seidu, S., Kunutsor, S. K., Ajjan, R., & Choudhary, P. (2023) · doi:10.2337/figshare.24291334.v1
Expanding Use of Continuous Glucose Monitoring in Type 2 Diabetes
Balata, S., Chiang, J., Hassan, A., & Reid, D. J. (2024) · ADCES in Practice · doi:10.1177/2633559x241296156
Sobczak, C., Oser, S. M., Warman, M., Daffron, A., Buss, D., Wettergreen, S. A., Oser, T. K., Parascando, J. A., & Jortberg, B. T. (2025) · ADCES in Practice · doi:10.1177/2633559x251328956
Clinical pharmacist roles in a virtual continuous glucose monitor initiation service
Wettergreen, S. A., Sobczak, C., Jortberg, B. T., Oser, S. M., Buss, D., Parascando, J. A., Daffron, A., & Oser, T. K. (2025) · JACCP JOURNAL OF THE AMERICAN COLLEGE OF CLINICAL PHARMACY · doi:10.1002/jac5.70046
Turner, L. V., Chen, C., Gao, P., Beck, S. E., Johnson, M. L., & Riddell, M. C. (2025) · Diabetes Technology and Obesity Medicine · doi:10.1177/29986702251393163
Calderon, A., Parascando, J. A., Westfeldt, E. B., Prince, B. K., Oser, S. M., & Oser, T. K. (2025) · American Journal of Health Promotion · doi:10.1177/08901171251399590
Karimi, N. (2025) · eScholarship (California Digital Library)
Karimi, N., CHOI, S. E., Song, Y., & Tolentino, D. A. (2026) · Journal of the American Association of Nurse Practitioners · doi:10.1097/jxx.0000000000001237
Liu, B., Hannah, K. L., Nemlekar, P. M., Green, C. R., & Norman, G. J. (2026) · Diabetes Metabolic Syndrome and Obesity · doi:10.2147/dmso.s574769
Consensus on Applications and Emerging Needs for Continuous Glucose Monitoring in Portugal
Neves, J. S., Teixeira, S., Neves, Â. S., Sampaio, L., Reis, M., Paiva, S., Mirante, A., Freitas, P., Nortadas, R., Melo, M., et al. (2026) · Endocrinology Insights · doi:10.1159/000551692
Abdelgader, H. E. A., Hamed, S. A. H., Sidahmed, H. A. A., Gehani, A.-L., Al-Shaikhli, A., Ali, A. E. U., Hajali, H. M. A., Elsamani, E. A. E. M., & Ahmed, A. (2026) · Cureus · doi:10.7759/cureus.106693
Ji, Y. (2026) · cIRcle (University of British Columbia)
Panjaitan, Y. R., Sari, R. D. I., & Lase, K. Y. (2025) · The International Journal of Medical Science and Health Research · doi:10.70070/ehg2p341
Liarakos, A. L., Randhay, A., Leelarathna, L., Crabtree, T. S. J., Doleman, B., Eldehni, M. T., Selby, N. M., Taal, M. W., Idris, I., & Wilmot, E. G. (2026) · Diabetes Obesity and Metabolism · doi:10.1111/dom.70954
Behavior Modifications From CUT-DM, Including Lifestyle Modification and Self-Efficacy
Vidovic, J., Vasconcelos, A. G., Berberian, P., Comstock, B. A., Montour, L., Wright, L. A.-C., & Ehrhardt, N. M. (2026) · Diabetes Obesity and Cardiometabolic CARE · doi:10.2337/doc25-0093 · Cited by 1
Hayek, A. A., Alzahrani, W. M., Ajlouni, M. M. A., & Dawish, M. A. A. (2026) · Journal of Diabetes & Metabolic Disorders · doi:10.1007/s40200-026-01982-9
Balaji, R. S., Vinith, V., Kannan, R., Ramadurai, M., & Murugan, P. (2026) · Obesity Medicine · doi:10.1016/j.obmed.2026.100724 · Cited by 1
Hannah, K. L., Nemlekar, P. M., & Norman, G. J. (2026) · Journal of Managed Care & Specialty Pharmacy · doi:10.18553/jmcp.2026.26112
Wang, X., Jiao, M., & Ma, W. (2026) · Diabetes Obesity and Metabolism · doi:10.1111/dom.71406
Hayek, A. A., Zahrani, W. M. A., Alotaibi, H. F., Jammal, M. E., & Dawish, M. A. A. (2026) · Journal of Diabetes Science and Technology · doi:10.1177/19322968261489265
Metadata
- Authors
- Cox, D. J., Banton, T., Moncrief, M., Conaway, M., Diamond, A., & McCall, A. L.
- Affiliations
- University of Virginia (US)
- Corresponding author
- Cox, Daniel J
- Venue
- Journal of the Endocrine Society
- Publisher
- The Endocrine Society
- Published
- 2020-08-18
- Volume
- 4
- Issue
- 11
- Pages
- bvaa118-bvaa118
- ISSN
- 2472-1972 (ISSN-L)
- PMC
- PMC7566397
- OpenAlex
- W3073688883
- Cited by
- 82
- References
- 15
- Citations by year
- 2026: 19 · 2025: 21 · 2024: 18 · 2023: 8 · 2022: 7 · 2021: 8 · 2020: 1
- FWCI
- 4.53
- Type
- journal article
- Language
- en
- Open access
- gold
- doi.org
- Licence
- Locations
- Journal of the Endocrine Society (publishedVersion, cc-by)
- PubMed Central (publishedVersion, cc-by)
- PubMed (publishedVersion)
- Funders
- Dexcom, Inc (IIS-2017-047)
- National Institutes of Health
- National Institute of Diabetes and Digestive and Kidney Diseases (DK108957)
- Topics
- Health Sciences › Medicine › Endocrinology, Diabetes and Metabolism › Diabetes Management and Research
- Health Sciences › Medicine › Endocrinology, Diabetes and Metabolism › Diabetes Management and Education
- Health Sciences › Medicine › Endocrinology, Diabetes and Metabolism › Diabetes Treatment and Management
- Keywords
- type 2 diabetes, continuous glucose monitoring, lifestyle intervention, glycemic control, HbA1c, diabetes medication reduction, carbohydrate intake, diabetes knowledge, diabetes distress, quality of life, patient empowerment, non-insulin-treated diabetes
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.